Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_assertion type Assertion NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_head.
- NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_assertion wasGeneratedBy ECO_0000203 NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_provenance.
- NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_assertion wasDerivedFrom befree-2016 NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_provenance.
- NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_assertion SIO_000772 24756793 NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_provenance.
- NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_assertion evidence source_evidence_literature NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_provenance.
- NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_assertion description "[The high efficacy of crizotinib in ALK- and ROS-positive lung cancer as new molecular targets beside the epidermal growth factor receptor (EGFR) underscores the importance of molecular typing in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175945.RACy_E2VHZWPlrWlmz5hmtYvrIGmfl1l8mRspYEpdtngc130_provenance.